全文获取类型
收费全文 | 1370篇 |
免费 | 115篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 46篇 |
妇产科学 | 6篇 |
基础医学 | 58篇 |
口腔科学 | 8篇 |
临床医学 | 148篇 |
内科学 | 330篇 |
皮肤病学 | 7篇 |
神经病学 | 90篇 |
特种医学 | 8篇 |
外科学 | 60篇 |
综合类 | 191篇 |
预防医学 | 427篇 |
眼科学 | 2篇 |
药学 | 92篇 |
中国医学 | 10篇 |
肿瘤学 | 18篇 |
出版年
2024年 | 3篇 |
2023年 | 44篇 |
2022年 | 104篇 |
2021年 | 109篇 |
2020年 | 104篇 |
2019年 | 75篇 |
2018年 | 88篇 |
2017年 | 54篇 |
2016年 | 46篇 |
2015年 | 48篇 |
2014年 | 120篇 |
2013年 | 129篇 |
2012年 | 99篇 |
2011年 | 99篇 |
2010年 | 63篇 |
2009年 | 47篇 |
2008年 | 40篇 |
2007年 | 49篇 |
2006年 | 31篇 |
2005年 | 25篇 |
2004年 | 24篇 |
2003年 | 10篇 |
2002年 | 13篇 |
2001年 | 16篇 |
2000年 | 17篇 |
1999年 | 9篇 |
1998年 | 4篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1976年 | 1篇 |
排序方式: 共有1502条查询结果,搜索用时 31 毫秒
151.
Victor W. Zhong Juhaeri Juhaeri Stephen R. Cole Christina M. Shay Penny Gordon-Larsen Evangelos Kontopantelis Elizabeth J. Mayer-Davis 《Journal of diabetes and its complications》2018,32(2):203-209
Aims
To determine association between HbA1C variability and hypoglycemia requiring hospitalization (HH) in adults with type 1 diabetes (T1D) and type 2 diabetes (T2D).Methods
Using nested case-control design in electronic health record data in England, one case with first or recurrent HH was matched to one control who had not experienced HH in incident T1D and T2D adults. HbA1C variability was determined by standard deviation of ≥ 3 HbA1C results. Conditional logistic models were applied to determine association of HbA1C variability with first and recurrent HH.Results
In T1D, every 1.0% increase in HbA1C variability was associated with 90% higher first HH risk (95% CI, 1.25–2.89) and 392% higher recurrent HH risk (95% CI, 1.17–20.61). In T2D, a 1.0% increase in HbA1C variability was associated with 556% higher first HH risk (95% CI, 3.88–11.08) and 573% higher recurrent HH risk (95% CI,1.59–28.51). In T2D for first HH, the association was the strongest in non-insulin non-sulfonylurea users (P < 0.0001); for recurrent HH, the association was stronger in insulin users than sulfonylurea users (P = 0.07). The HbA1C variability-HH association was stronger in more recent years in T2D (P ≤ 0.004).Conclusions
HbA1C variability is a strong predictor for HH in T1D and T2D. 相似文献152.
Pre‐discharge and early post‐discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial
下载免费PDF全文
![点击此处可从《European journal of heart failure》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Stephen J. Greene Javed Butler Gregg C. Fonarow Haris P. Subacius Andrew P. Ambrosy Muthiah Vaduganathan Marco Triggiani Scott D. Solomon Eldrin F. Lewis Aldo P. Maggioni Michael Böhm Ovidiu Chioncel Savina Nodari Michele Senni Faiez Zannad Mihai Gheorghiade for the ASTRONAUT Investigators Coordinators 《European journal of heart failure》2018,20(2):281-291
Aims
Troponin levels are commonly elevated among patients hospitalized for heart failure (HF), but the prevalence and prognostic significance of early post‐discharge troponin elevation are unclear. This study sought to describe the frequency and prognostic value of pre‐discharge and post‐discharge troponin elevation, including persistent troponin elevation from the inpatient to outpatient settings.Methods and results
The ASTRONAUT trial (NCT00894387; http://www.clinicaltrials.gov ) enrolled hospitalized HF patients with ejection fraction ≤40% and measured troponin I prior to discharge (i.e. study baseline) and at 1‐month follow‐up in a core laboratory (elevation defined as >0.04 ng/mL). This analysis included 1469 (91.0%) patients with pre‐discharge troponin data. Overall, 41.5% and 29.9% of patients had elevated pre‐discharge [median: 0.09 ng/mL; interquartile range (IQR): 0.06–0.19 ng/mL] and 1‐month (median: 0.09 ng/mL; IQR: 0.06–0.15 ng/mL) troponin levels, respectively. Among patients with pre‐discharge troponin elevation, 60.4% had persistent elevation at 1 month. After adjustment, pre‐discharge troponin elevation was not associated with 12‐month clinical outcomes. In contrast, 1‐month troponin elevation was independently predictive of increased all‐cause mortality [hazard ratio (HR) 1.59, 95% confidence interval (CI) 1.18–2.13] and cardiovascular mortality or HF hospitalization (HR 1.28, 95% CI 1.03–1.58) at 12 months. Associations between 1‐month troponin elevation and outcomes were similar among patients with newly elevated (i.e. normal pre‐discharge) and persistently elevated levels (interaction P ≥ 0.16). The prognostic value of 1‐month troponin elevation for 12‐month mortality was driven by a pronounced association among patients with coronary artery disease (interaction P = 0.009).Conclusions
In this hospitalized HF population, troponin I elevation was common during index hospitalization and at 1‐month follow‐up. Elevated troponin I level at 1 month, but not pre‐discharge, was independently predictive of increased clinical events at 12 months. Early post‐discharge troponin I measurement may offer a practical means of risk stratification and should be investigated as a therapeutic target.153.
154.
目的:分析急性心肌梗死患者实施程序化护理的效果。方法:选择在本院接受治疗的72例急性心肌梗死患者作为研究对象,分别给予常规护理及程序化护理干预,比较2组患者的死亡率及平均住院时间。结果:程序化护理的观察组平均住院时间12.31±3.94天明显短于对照组(t=3.242,p0.05);患者死亡率(5.56%)明显低于对照组(x2=2.486,P0.05)。结论:程序化护理可以有效降低急性心肌梗死患者的死亡率,加快其康复速度,缩短住院时间。 相似文献
155.
目的在于调查分析唐山某钢厂炼铁工人住院率及其影响因素。方法采用自行设计的调查问卷对唐山市某钢厂全体炼铁北区2325名工人进行一对一问卷调查。结果问卷有效回收率为93.96%。结果显示年龄、工龄和饮酒情况对住院率的影响差异有统计学意义(P〈0.05),性别、婚姻状况和吸烟情况对其影响不显著(P〉0.05)。结论调查对象中年龄较大和工龄较长的住院率较高,建议可适当对年龄大工龄长的职工增加健康教育和健康促进等干预措施。 相似文献
156.
Elham Mahmoudi Michelle A. Meade Martin B. Forchheimer Denise C. Fyffe James S. Krause Denise Tate 《Archives of physical medicine and rehabilitation》2014
Objective
To examine the longitudinal effects of race/ethnicity on hospitalization among adults with spinal cord injury (SCI) in the 10-year period after initial injury.Design
Retrospective analysis of postinjury hospitalizations among non-Hispanic white, non-Hispanic African American, and Hispanic adults with SCI.Setting
Community. Data were extracted from the 2011 National Spinal Cord Injury Model Systems database.Participants
Patients with traumatic SCI (N= 5146; white, 3175; African American, 1396; Hispanic, 575) who received rehabilitation at one of the relevant SCI Model Systems.Interventions
Not applicable.Main Outcome Measures
Hospitalization, including rate of hospitalization, number of hospitalizations, and number of days hospitalized during the 12 months before the first-, fifth-, and tenth-year follow-up interviews for the SCI Model Systems.Results
Significant differences were found in rates of hospitalization at 1 and 5 years postinjury, with participants from Hispanic backgrounds reporting lower rates than either whites or African Americans. At 10 years postinjury, no differences were noted in the rate of hospitalization between racial/ethnic groups; however, compared with whites (P=.011) and Hispanics (P=.051), African Americans with SCI had 13 and 16 more days of hospitalization, respectively. Compared with the first year postinjury, the rate of hospitalization declined over time among whites, African Americans, and Hispanics; however, for African Americans, the number of days hospitalized increased by 12 days (P=.036) at 10 years versus 5 years postinjury.Conclusions
Racial/ethnic variation appears to exist in postinjury hospitalization for individuals with SCI, with Hispanics showing the lowest rates of hospitalization at 1 and 5 years postinjury and African Americans having a significantly higher number of days hospitalized at 10 years postinjury. Potential explanations for these variations are discussed, and recommendations are made for potential changes to policy and clinical care. 相似文献157.
Objective
To evaluate the effects of whole-body resistance training on exercise capacity, health-related quality of life (HRQOL), and muscle strength in patients hospitalized for exacerbation of chronic obstructive pulmonary disease.Design
Randomized controlled trial.Setting
University hospital.Participants
Patients (N=46) were randomized to either a control group (CG) or training group (TG), and 29 patients completed the study.Intervention
Training consisted of weight-lifting exercises for 6 muscle groups in the upper and lower limbs (2 sets of 8 repetitions each), and the initial load was set at 80% of the 1-repetition maximum load.Main Outcome Measures
Patients were evaluated on the second day of hospitalization, at hospital discharge, and 30 days postdischarge. Patients were evaluated on the basis of the 6-minute walking distance (6MWD), HRQOL, muscle strength, systemic inflammatory markers, and level of physical activity in daily life (PADL).Results
The CG showed a reduction in the strength of lower-limb muscles (P<.05) but not in the 6MWD (P>.05). In contrast, patients from the TG improved strength in the lower-limb muscles and 6MWD during and 30 days after hospitalization (P<.05). The TG also improved the impact domain in HRQOL after hospitalization. No improvement in PADL was observed in the TG. Finally, a reduction in the blood levels of inflammatory markers was observed only in the TG after hospitalization.Conclusions
Our results suggest that resistance training during hospitalization improves the 6MWD, HRQOL, and lower-limb muscle strength, without altering the levels of systemic inflammation. However, future research should explore this intervention in larger randomized trials. 相似文献158.
《Journal of infection and chemotherapy》2022,28(2):146-157
IntroductionRespiratory syncytial virus (RSV) is one of the most common causes of lower respiratory tract infections in children aged <5 years and is associated with long-term respiratory morbidities such as recurrent wheezing and asthma, decreased lung function, and allergic sensitization. The objective of this review was to evaluate the epidemiology and burden of RSV infection in the pediatric population in Japan.MethodsStudies indexed in PubMed and ICHUSHI databases during January 2010–December 2020 were manually reviewed. Data on proportion of RSV infections, seasonality, length of stay (LoS), mortality, medical expenses, and palivizumab use were extracted from the selected articles.ResultsNinety-three articles were included (PubMed, 64; ICHUSHI, 29). The proportion of patients/samples with an RSV infection was 5.5%–66.7%, and 6.0%–29.9% in the inpatient and outpatient departments, respectively. RSV infections generally occurred during autumn/winter; however, recently the peak has shifted to summer. The LoS was variable and depended on factors such as age, infection severity, wheezing, and RSV subgroups. Mortality rates varied from <1% to 19% depending on the infection severity. The average daily hospitalization and intensive care unit cost was JPY 34,548 while intensive care unit incurred an additional cost of JPY 541,293. Palivizumab was indicated for high-risk infants and 0%–3% of patients required hospitalization despite palivizumab use.ConclusionsRSV imposes a significant burden on the Japanese healthcare system, suggesting a need to create awareness among caregivers of children, pregnant women and healthcare professionals to ensure early recognition of infection and adequate treatment or prophylaxis. 相似文献
159.
《Journal of infection and chemotherapy》2022,28(7):853-858
IntroductionInfluenza remains a clinically heavy burden worldwide. It is well known that some populations are at high risk of complications from influenza, whereas, even previously healthy people might suffer from severe influenza.The objective of this study was to clarify clinical manifestations of hospitalized patients without risk factors infected with influenza.MethodsThe clinical data for patients who were severely ill with influenza, and required hospitalization were gathered and analyzed between November 2014 and August 2020 (6 influenza seasons) using an internet-surveillance system. Among them, the patients who had no risk factors of complications from influenza were extracted.ResultsFinally, a total of 91 patients (9.0% of all influenza-related hospitalizations) without risk factors were analyzed. The no risk group was younger than the risk group, though other significant differences of clinical characteristics were not recognized between the groups. Pneumonia was the most common cause of hospitalization in the no risk group, and primary influenza viral pneumonia was the most common pneumonia. Antiviral drugs were administered in 96.7% of the no-risk group, and artificial ventilation was performed in 18.7%. In-hospital death was recorded for 3 patients without risk factors.ConclusionsSevere complications of influenza which required hospitalization may occur in a certain degree of patients with no risk factors. Efforts are needed to diagnose and treat influenza appropriately even in previously healthy younger patients. Continuous nationwide surveillance will be required to clarify risk factors for severe influenza even in previously healthy younger patients.(UMIN000015989). 相似文献
160.
Leonardo Marques Fischer Jo?o Pedro Passos Dutra Augusto Mantovani Gustavo Glotz de Lima Tiago Luiz Luz Leiria 《Arquivos brasileiros de cardiologia》2013,101(6):480-486